Autolus Therapeutics plc (AUTL) Financials
AUTL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 375.4 million | 263.9 million |
2023-09-30 | 406.1 million | 225.6 million |
2023-06-30 | 451.0 million | 221.7 million |
2023-03-31 | 460.0 million | 193.1 million |
AUTL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -26.3 million | 3.3 million |
2023-09-30 | -41.7 million | 2.9 million |
2023-06-30 | -42.5 million | 2.7 million |
2023-03-31 | -46.0 million | 2.4 million |
AUTL Net Income
No data available :(
AUTL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 53.0 million |
2023-09-30 | 256.4 million | - | 52.5 million |
2023-06-30 | 307.5 million | - | 50.9 million |
2023-03-31 | 343.0 million | - | 27.3 million |
AUTL Shares Outstanding
AUTL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.5 million | 25.2 million | 15.7 million | - |
2023-09-30 | 1.5 million | 37.2 million | 10.6 million | - |
2023-06-30 | 4.4 million | 36.7 million | 11.1 million | - |
2023-03-31 | 3.6 million | 31.3 million | 9.3 million | - |
AUTL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 406000 | 382000 |
2023-06-30 | - | 1.5 million |
2023-03-31 | 1.3 million | 1.9 million |
AUTL
Price: $4.08
52 week price:
Earnings Per Share: -1.20 USD
P/E Ratio: -6.15
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 412700
Market Capitalization: 1.3 billion